Emerging Opportunities of Whole Exome Sequencing Market, In-Depth Research Study, Future Trends and Forecast 2028

Emerging research logo

Whole-exome sequencing is a widely used and important next-generation sequencing technique that efficiently sequences all protein-coding regions in a genome.

Increasing research and development activities, advancements in genomics, and growing awareness about the benefits of whole exome sequencing are key factors expected to drive the growth of the marketโ€

โ€” Emerging research

VANCOUER, BC, CANADA, June 1, 2022 /EINPresswire.com/ โ€” The global whole exome sequencing market size is expected to be considerably robust in 2028 and register a stable revenue CAGR during the period forecast, according to the latest report from Emergen Search. Rising incidence of genetic disorders, rising awareness of whole exome sequencing, and rapid development of advanced diagnostic methods for the treatment of genetic disorders are key factors that are expected to drive the market revenue growth. Furthermore, whole exome sequencing is cost effective compared to whole genome sequencing methods and has higher efficiency in detecting genetic variations or mutations that alter protein sequences, which has boosted its adoption in research. scholar and scientist.

Get FREE Sample Copy of Whole Exome Sequencing Market Report @ https://www.emergenresearch.com/request-sample/790

Market dynamics:

Whole-exome sequencing is a widely used and important next-generation sequencing technique that efficiently sequences all protein-coding regions in a genome. Whole exome sequencing is primarily used to screen and identify variations and mutations in protein coding regions. Whole exome sequencing can accurately detect genetic mutations linked to birth defects and developmental delays. Increased awareness of the benefits of whole exome sequencing in detecting genetic disorders, increased investment to accelerate genomics and proteomics research, and adoption of advanced technologies are key factors expected to drive growth market revenue over the forecast period.

๐–๐ก๐จ๐ฅ๐ž ๐„๐ฑ๐จ๐ฆ๐ž ๐’๐ž๐ช๐ฎ๐ž๐ง๐œ๐ข๐ง๐  ๐Œ๐š๐ซ๐ค๐ž๐ญ: ๐‚๐จ๐ฆ๐ฉ๐ž๐ญ๐ข๐ญ๐ข๐ฏ๐ž ๐‹๐š๐ง๐๐ฌ๐œ๐š๐ฉ๐ž

Key players operating in the whole exome sequencing market are profiled in detail in the report along with their strategies, collaborations, and product innovations. The analysis of key players and their strategies to strengthen their presence in the market provides insight into the competitive landscape of the Electronic Health Records market.

๐Œ๐š๐ฃ๐จ๐ซ ๐‚๐จ๐ฆ๐ฉ๐š๐ง๐ข๐ž๐ฌ ๐ข๐ง ๐ญ๐ก๐ž ๐†๐ฅ๐จ๐›๐š๐ฅ ๐„๐ฑ๐จ๐ฆ๐ž ๐„๐ฑ๐จ๐ฆ๐ž ๐’๐ž๐ช๐ฎ๐ž๐ง๐œ๐ข๐ง๐  ๐ˆ๐ง๐œ๐ฅ๐ฎ๐๐ž ๐ˆ๐ง๐œ๐ฅ๐ฎ๐๐ž:
Illumina, Inc.
Life technologies
Roche NimbleGen, Inc.
BGI (Beijing Genomics Institute)
Eurofins Genomics, Inc.
Knome, Inc.
Macrogene, Inc.
Amber genetics

๐’๐ž๐ซ๐ฏ๐ข๐œ๐ž๐ฌ ๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ ๐€๐œ๐œ๐จ๐ฎ๐ง๐ญ๐ž๐ ๐Ÿ๐จ๐ซ ๐‹๐š๐ซ๐ ๐ž๐ฌ๐ญ ๐‘๐ž๐ฏ๐ž๐ง๐ฎ๐ž ๐’๐ก๐š๐ซ๐ž ๐ข๐ง ๐Ÿ๐ŸŽ๐Ÿ๐ŸŽ:

The services segment accounted for the largest revenue share in the global market in 2020. The services are further segmented into sequencing and data analysis services. Rising demand for high-throughput sequencing and data analysis services owing to their advantages such as advanced bioinformatics visualization and low-cost sequencing and data management is a key driver for the growth of this segment. Sequence analysis services typically include experimental design, generation of libraries from samples, and downstream analysis of DNA sequences.

๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐‚๐ž๐ง๐ญ๐ž๐ซ๐ฌ & ๐€๐œ๐š๐๐ž๐ฆ๐ข๐œ ๐ˆ๐ง๐ฌ๐ญ๐ข๐ญ๐ฎ๐ญ๐ข๐จ๐ง๐ฌ ๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ ๐ญ๐จ ๐€๐œ๐œ๐จ๐ฎ๐ง๐ญ ๐Ÿ๐จ๐ซ ๐‘๐ž๐ฏ๐ž๐ง๐ฎ๐ž ๐‚๐€๐†๐‘ ๐‚๐€๐†๐‘:

On the basis of end-use, the global whole exome sequencing market is segmented into hospitals and clinics, pharmaceutical and biotechnology companies, research centers and academic institutions, and others. The research centers and academic institutions segment is expected to register the fastest revenue growth rate during the forecast period. Factors contributing to the growth of this segment are increasing demand for advanced therapies and personalized medicine, increasing investment by government agencies in genomic research programs, increasing use of whole exome sequencing in laboratories of clinical genetics and the increasing use of technology in the diagnosis and treatment of cancer and other chronic diseases.

๐๐จ๐ซ๐ญ๐ก ๐€๐ฆ๐ž๐ซ๐ข๐œ๐š ๐€๐œ๐œ๐จ๐ฎ๐ง๐ญ๐ž๐ ๐Ÿ๐จ๐ซ ๐‹๐š๐ซ๐ ๐ž๐ฌ๐ญ ๐‘๐ž๐ฏ๐ž๐ง๐ฎ๐ž ๐’๐ก๐š๐ซ๐ž ๐ข๐ง ๐Ÿ๐ŸŽ๐Ÿ๐ŸŽ:

Among regional markets, North America whole exome sequencing market accounted for the largest revenue share in the global market in 2020. Rising prevalence of chronic and genetic disorders, growing demand for personalized medicine, growing adoption of whole exome sequencing technology for the development of advanced diagnostics and increasing genomics R&D activities are major factors supporting the North America market revenue growth. Revenue growth is further driven by factors such as increased government funding for cancer research and the presence of major market players in the region including Illumina, Inc., Agilent Technologies and Life Technologies.

๐€๐œ๐œ๐ž๐ฌ๐ฌ ๐ญ๐ก๐ž ๐„๐ง๐ญ๐ข๐ซ๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐ฉ๐š๐œ๐ค๐ž๐ ๐ฐ๐ข๐ญ๐ก ๐“๐Ž๐‚ ๐“๐Ž๐‚ ๐“๐š๐›๐ฅ๐ž๐ฌ ๐“๐š๐›๐ฅ๐ž๐ฌ ๐š๐ง๐ ๐…๐ข๐ ๐ฎ๐ซ๐ž๐ฌ ๐š๐ง๐ ๐จ๐Ÿ ๐๐ซ๐จ๐ฆ๐ข๐ง๐ž๐ง๐ญ ๐๐ซ๐จ๐ฆ๐ข๐ง๐ž๐ง๐ญ ๐‚๐จ๐ฆ๐ฉ๐š๐ง๐ข๐ž๐ฌ @ https://www.emergenresearch.com/indudustry-report/whole-exome-senence-market

๐†๐ฅ๐จ๐›๐š๐ฅ ๐–๐ก๐จ๐ฅ๐ž ๐„๐ฑ๐จ๐ฆ๐ž ๐’๐ž๐ช๐ฎ๐ž๐ง๐œ๐ข๐ง๐  ๐Œ๐š๐ซ๐ค๐ž๐ญ:

Emergen Research has segmented the global Blockchain in Genomics market on the basis of service, business model, application, end-use, and region:

Service Outlook (Revenue, USD Million; 2017-2027)

Business Model Outlook (Revenue, USD Million; 2017-2027)
Business to Customer (B2C)
Business to business (B2B)
Customer to business (C2B)

Application Outlook (Revenue, USD Million; 2017-2027)
Data storage and security
Data sharing and monetization
Automated health insurance

End-Use Outlook (Revenue, USD Million; 2017-2027)
Pharmaceuticals and biotechnology
Research institutes

๐–๐ก๐จ๐ฅ๐ž ๐„๐ฑ๐จ๐ฆ๐ž ๐’๐ž๐ช๐ฎ๐ž๐ง๐œ๐ข๐ง๐  ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ ๐ข๐ง๐ช๐ฎ๐ข๐ซ๐ฒ ๐š๐ง๐ ๐ซ๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐Ÿ๐จ๐ซ ๐œ๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐š๐ญ๐ข๐จ๐ง @ https://www.emergenresearch.com/request-for-custumization/790

Geographically, this report studies key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering:

United States




South East Asia


We can also provide custom regional or country reports for the following regions:

North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, United Kingdom, Italy, Spain, Russia, Rest of Europe, Central and South America, Brazil, Argentina, Rest of South America, Middle East and Africa, Saudi Arabia, Turkey, Rest of Middle East and Africa

๐–๐ก๐ฒ ๐ฌ๐ก๐จ๐ฎ๐ฅ๐ ๐ฒ๐จ๐ฎ ๐›๐ฎ๐ฒ ๐ญ๐ก๐ข๐ฌ ๐„๐ฑ๐จ๐ฆ๐ž ๐„๐ฑ๐จ๐ฆ๐ž ๐’๐ž๐ช๐ฎ๐ž๐ง๐œ๐ข๐ง๐  ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ?

The study document dissects the total market potential of major regions along with strengths, opportunities and challenges, restraints and dangers.
Identifying high-improvement locations, the study inspects open entries, keeping an eye out for accomplices.
It examines each submarket in terms of a unique improvement design and its contribution to the market.
It reviews recent developments, such as breakthroughs, business strategies, new product launches, and acquisitions.
It deliberately profiles the major players in the market and thoroughly studies their strategies for advancement.

๐“๐š๐ค๐ž ๐š ๐‹๐จ๐จ๐ค ๐š๐ญ ๐จ๐ฎ๐ซ :

single cell sequencing market


synthetic blood substitutes market


rehabilitation robotics market


alopecia market


brachytherapy market


depression treatment market


electrosurgical devices market


๐€๐›๐จ๐ฎ๐ญ ๐”๐ฌ:

At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting firm with an extensive knowledge base on cutting-edge and potentially market-disrupting technologies that are expected to become more prevalent over the next decade.

Thank you for reading our report. For more details or to inquire about customization, please let us know. We will offer you the report according to your requirement.

Eric Lee
Emerging research
+91 90210 91709
[email protected]
Visit us on social media:

Paul N. Strickland